Compare Stocks → Could Your Accounts Be Frozen? (From Allegiance Gold) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NYSE:ARACVE:CAVNASDAQ:HECNYSE:WRI Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeARAAmerican Renal Associates$11.52$11.50$5.57▼$11.98$397.94M1.11106,940 shs9,831 shsCAVCamrova ResourcesC$0.07+∞C$0.06C$0.06▼C$0.11C$1.50MN/A17,375 shs9,208 shsHECHudson Executive Investment$3.17+1.3%$8.58$7.82▼$12.45$131.24MN/A1.42 million shs530,543 shsWRIWeingarten Realty Investors$31.44$31.75$15.24▼$34.24$4.01B1.571.25 million shs26.46 million shs5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceARAAmerican Renal Associates0.00%0.00%0.00%0.00%0.00%CAVCamrova Resources0.00%0.00%0.00%0.00%0.00%HECHudson Executive Investment+1.28%+2.92%-12.91%+29.39%+299.65%WRIWeingarten Realty Investors0.00%0.00%0.00%0.00%0.00%Investors Alert: The Next Big Thing in Weight Loss (Ad)UBS bank predicts it will become "The Biggest Drug Ever." The Wall Street Journal believes it will be "Pharma's biggest blockbuster yet." Bank of America predicts it will be the world's first "$100 billion dollar a year drug." And Morgan Stanley predicts 250 million prescriptions will be written each year. Get the name of the stock here >>> MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationARAAmerican Renal AssociatesN/AN/AN/AN/AN/AN/AN/AN/ACAVCamrova ResourcesN/AN/AN/AN/AN/AN/AN/AN/AHECHudson Executive InvestmentN/AN/AN/AN/AN/AN/AN/AN/AWRIWeingarten Realty InvestorsN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceARAAmerican Renal AssociatesN/AN/AN/AN/ACAVCamrova ResourcesN/AN/AN/AN/AHECHudson Executive InvestmentN/AN/AN/AN/AWRIWeingarten Realty InvestorsN/AN/AN/AN/ASales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookARAAmerican Renal Associates$822.52M0.48$1.69 per share6.80$2.59 per share4.45CAVCamrova ResourcesC$7.51K199.17C$0.01 per share10.00C($0.04) per share-1.86HECHudson Executive InvestmentN/AN/AN/AN/A$0.12 per shareN/AWRIWeingarten Realty Investors$433.92M9.25$2.02 per share15.53$13.95 per share2.25Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateARAAmerican Renal Associates-$13.79M$0.26N/AN/AN/A-2.04%-3.56%-0.24%N/ACAVCamrova ResourcesN/A-C$0.03N/A∞N/AN/AN/AN/AN/AHECHudson Executive Investment-$27.24MN/A0.00∞N/AN/A-337.48%-4.06%N/AWRIWeingarten Realty Investors$112.15M$1.6544.9117.182.7118.97%4.93%2.27%N/ADividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthARAAmerican Renal AssociatesN/AN/AN/AN/AN/ACAVCamrova ResourcesN/AN/AN/AN/AN/AHECHudson Executive InvestmentN/AN/AN/AN/AN/AWRIWeingarten Realty Investors$0.922.93%N/A55.76%N/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioARAAmerican Renal Associates7.541.051.02CAVCamrova ResourcesN/A0.010.01HECHudson Executive InvestmentN/A0.330.33WRIWeingarten Realty Investors1.001.621.58OwnershipInstitutional OwnershipCompanyInstitutional OwnershipARAAmerican Renal Associates78.42%CAVCamrova ResourcesN/AHECHudson Executive Investment73.41%WRIWeingarten Realty Investors85.19%Insider OwnershipCompanyInsider OwnershipARAAmerican Renal Associates9.50%CAVCamrova ResourcesN/AHECHudson Executive InvestmentN/AWRIWeingarten Realty Investors6.60%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableARAAmerican Renal Associates4,97734.54 millionN/AOptionableCAVCamrova ResourcesN/A23.01 millionN/ANot OptionableHECHudson Executive InvestmentN/A41.40 millionN/ANot OptionableWRIWeingarten Realty Investors243127.63 millionN/AOptionableARA, HEC, WRI, and CAV HeadlinesSourceHeadlineAmerican Realty Investors Inc ARLmorningstar.com - November 8 at 2:35 PMFive Eye-Popping Truths Investors Need To Know About Manhattan Real Estateforbes.com - September 29 at 12:54 PMRandi Weingarten attack on DeSantis over education backfires: 'Literally closed every school in the country'msn.com - August 24 at 3:40 PMInvestors Edge Real Estatedomain.com.au - July 29 at 1:07 PMOn Randi Weingarten’s Waterfrontmsn.com - May 2 at 9:27 PMUFT loves charters . . . as long as Randi Weingarten is involvedmsn.com - April 28 at 9:19 PMTeachers Union President Randi Weingarten testifies before Congress on Covid-19 school closuresedsource.org - April 27 at 12:34 AMRandi Weingarten is the shame of the nationnypost.com - April 20 at 8:56 PMEllis Martin Report: The Astrologers Fund's Henry Weingarten-Yellow Alert!marketwatch.com - April 18 at 7:50 AMInvestors Retreat From Commercial Real Estate Bondswsj.com - April 8 at 12:18 PMLeft-wing antisemitism and Randi Weingarten’s Jewish conspiracy theorieswashingtontimes.com - April 4 at 6:44 PMHow to Start Investing in Real Estate: The Basicsfool.com - April 1 at 8:24 PMInvestors bought 1 in 4 homes in D-FW last year. Most were not big Wall Street firmsdallasnews.com - March 21 at 11:24 PMReal-estate investors said eliminating a popular tax-avoidance tool would damage the economybusinessinsider.com - March 18 at 1:21 PMUnderstanding the 1% rule for real estate investorsfinance.yahoo.com - March 12 at 6:54 PMWhat ESG Means for Real Estate Investorswealthmanagement.com - February 25 at 3:41 PMTCIseekingalpha.com - February 22 at 9:23 PMProperty investors may lose tax breaks in real estate reformstimesofisrael.com - February 18 at 7:06 PMTax Benefits for Active and Passive Real Estate Investorsmorningstar.com - January 27 at 11:08 PMEuropean investors cut allocations to real estate -surveyreuters.com - January 25 at 1:15 PMReal estate investors’ golden rules for an uncertain 2023heraldsun.com.au - January 25 at 8:15 AMReal Estate Syndicationbenzinga.com - January 12 at 8:09 PMThe 6 best podcasts for commercial real estate investors in 2023businessinsider.com - January 5 at 12:54 PMWho’s Afraid of Randi Weingarten?wsj.com - December 6 at 6:48 PMNew MarketBeat Followers Over TimeTop Headlines3 Stocks Leading the U.S. Agriculture ComebackApril 26, 2024 10:10 AMView 3 Stocks Leading the U.S. Agriculture ComebackChecking in with 5 Bitcoin Stocks Ahead of Bitcoin's HalvingApril 17, 2024 7:10 AMView Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's HalvingJohnson & Johnson’s Q1 Checkup: Mixed Results, Optimism RemainsApril 17, 2024 7:40 AMView Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism RemainsWhat is a Secular Bull Market? How to Identify this MarketApril 16, 2024 7:59 AMView What is a Secular Bull Market? How to Identify this MarketRoku Trims Losses and Raises Guidance, But Market Isn’t ConvincedApril 29, 2024 6:15 AMView Roku Trims Losses and Raises Guidance, But Market Isn’t ConvincedAll Headlines Company DescriptionsAmerican Renal AssociatesNYSE:ARAAmerican Renal Associates Holdings, Inc. operates as a dialysis services provider in the United States. It operates dialysis clinics focusing on joint venture partnerships with physicians. The company offers kidney dialysis services to patients suffering from chronic kidney failure or end stage renal disease. As of December 31, 2019, it operated 246 dialysis clinics in partnership with 400 nephrologist partners treating approximately 17,300 patients in 27 states and the District of Columbia. The company was founded in 1999 and is headquartered in Beverly, Massachusetts.Camrova ResourcesCVE:CAVCamrova Resources Inc., a mining company, engages in the acquisition, exploration and development of resource properties. It owns a 7.23% interest in the Boleo copper-cobalt-zinc-manganese project located in Baja California Sur, Mexico. The company was formerly known as Baja Mining Corp. and changed its name to Camrova Resources Inc. in October 2016. Camrova Resources Inc. was incorporated in 1985 and is based in Vancouver, Canada.Hudson Executive InvestmentNASDAQ:HECHudson Executive Investment Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.Weingarten Realty InvestorsNYSE:WRIWeingarten Realty Investors (NYSE: WRI) is a shopping center owner, manager and developer. At September 30, 2020, the Company owned or operated under long-term leases, either directly or through its interest in real estate joint ventures or partnerships, a total of 162 properties which are located in 15 states spanning the country from coast to coast. These properties represent approximately 31.0 million square feet of which our interests in these properties aggregated approximately 21.0 million square feet of leasable area. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.